Executive Director/Vice President, Medical Affairs – Genetic Rare Disease

The Opportunity

As Executive Director/Vice President, Medical Affairs, Vascular Anomalies, you will define and implement all aspects of clinical trial engagement, disease awareness, and medical strategy for Relay Tx’s vascular anomalies program as it advances from late-stage clinical development through launch and commercialization. You will lead the Medical Affairs function through this pivotal transition from late-stage development to commercialization readiness, partnering closely with internal and external stakeholders to develop solutions that drive awareness of Relay Therapeutics' genetic vascular anomaly portfolio, incorporate critical insights into medical strategy, and build external networks and partnerships to advance clinical trials, patient identification, and access to specialized care. We are seeking an individual who is an excellent communicator with strong interpersonal skills, a skilled relationship builder and experienced in leading a medical organization into and through rare disease commercialization.

Your Role

• Plan, develop, and execute an integrated Medical Affairs strategy with internal and external stakeholders, key opinion leaders (KOLs), clinical sites, and patients for Relay Tx’s vascular anomaly programs.
• Lead Medical Affairs planning for a late-stage program progressing toward potential commercialization, partnering cross-functionally to support launch readiness, evidence generation, scientific communications, and external expert engagement.
• Establish and maintain credible scientific interactions with national and regional opinion leaders, clinicians, researchers, and centers of excellence focused on vascular anomalies.
• Build the scientific platform and lead publication planning and execution, ensuring a coherent data narrative across congresses, peer-reviewed literature, and medical education as the program moves toward approval.
• Serve as a subject matter expert in vascular anomalies and provide critical medical input into the development strategies of clinical programs.
• Evolve the field medical strategy from trial enrollment and investigator engagement toward launch-stage scientific engagement, patient identification at scale, and treating-center capability building.
• Provide leadership for congress strategy and key opinion leader engagement, including proactive facilitation of thought leader interactions and comprehensive review and presentation of key insights and feedback.
• Plan and conduct Medical Advisory Boards in collaboration with external partners to obtain critical feedback and insights on Relay Tx’s vascular anomaly programs.
• Lead development of disease-state and protocol-level communication plans with external stakeholders and partners to drive trial awareness and referral of potential patients.
• Work in tandem with the head of vascular anomaly patient advocacy to build relationships with genetic counselors, specialty treatment centers, academic institutions, and patient advocacy organizations to support patient identification and referral pathways.
• Design and build the field medical organization required at launch, including MSL team scaling, territory and center-of-excellence coverage models, and metrics that shift from enrollment support to scientific engagement and treating-center readiness.
• Coach, develop, and retain a high-performing team by creating and providing opportunities for learning and advancement.

Your Background

• Health sciences advanced or doctoral degree, such as a PharmD, MD, or PhD highly preferred. PA, MSN, NP, DNP accompanied by previous pharmaceutical industry or clinical research experience in the area of genetic s, inherited disorders, medical genetics, or related therapeutic areas will be considered.
• Clinical or prior pharmaceutical industry experience in rare disease is strongly preferred.
• 10+ years clinical or pharmaceutical experience with a minimum of 8 years of experience in field medical, medical affairs, or clinical trial engagement roles.
• Demonstrated expertise in genetic rare diseases, inherited disorders, genomic medicine, or orphan drug development preferred.
• Understanding of local medical practice and clinical decision making as it pertains to patient care.
• Ability to interpret scientific data and translate this information to meet educational, clinical and research needs.
• Understanding of the design and execution of research studies.
• Exemplary communication and presentation skills.
• Ability to think strategically and collaborate effectively.
• Ability and willingness to travel.
• Track record of successfully meeting or exceeding clinical trial timelines and patient recruitment goals in rare disease, specialty care, or complex patient populations.
• History of building long-term relationships with specialty treatment centers, genetic counselors, advocacy organizations, investigators, and other key rare disease stakeholders.
• Familiarity with effective digital clinical trial communication technologies.
• Demonstrated expertise in CFR and GCP/ICH requirements and European Clinical Trial Directive.

 

Estimated Salary Range: [$225,000 - $321,000].

The range provided above is based on what we believe to be a reasonable estimate for this job at the time of posting. Actual base salary will depend on a number of factors, including but not limited to, a candidate’s education, experience, skills and location.

 

 

#BP1

About Relay Therapeutics

Relay Therapeutics is a clinical-stage precision medicines company transforming the drug discovery process with the goal of bringing life-changing therapies to patients. Built on unparalleled insights into protein motion and how this dynamic behavior relates to protein function, we aim to effectively drug protein targets that have previously been intractable, with an initial focus on enhancing small molecule therapeutic discovery in targeted oncology. Our Dynamo platform integrates an array of leading-edge experimental and computational approaches to provide a differentiated understanding of protein structure and motion to drug these targets. We have built a world-class team of leading experts from each of these disciplines, and they are driven by a deep collaboration at every step of our drug discovery process.  

Our team is equal parts fearless and relentless, with a shared passion for working collaboratively in intellectually stimulating environments. If you’re excited by the challenge of putting protein motion at the heart of drug discovery and passionate about making a difference in the lives of patients, join us!